UniProt ID | COHA1_HUMAN | |
---|---|---|
UniProt AC | Q9UMD9 | |
Protein Name | Collagen alpha-1(XVII) chain | |
Gene Name | COL17A1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1497 | |
Subcellular Localization |
Cell junction, hemidesmosome. Membrane Single-pass type II membrane protein. Localized along the plasma membrane of the hemidesmosome. 120 kDa linear IgA disease antigen: Secreted, extracellular space, extracellular matrix, basement membrane. |
|
Protein Description | May play a role in the integrity of hemidesmosome and the attachment of basal keratinocytes to the underlying basement membrane.; The 120 kDa linear IgA disease antigen is an anchoring filament component involved in dermal-epidermal cohesion. Is the target of linear IgA bullous dermatosis autoantibodies.. | |
Protein Sequence | MDVTKKNKRDGTEVTERIVTETVTTRLTSLPPKGGTSNGYAKTASLGGGSRLEKQSLTHGSSGYINSTGSTRGHASTSSYRRAHSPASTLPNSPGSTFERKTHVTRHAYEGSSSGNSSPEYPRKEFASSSTRGRSQTRESEIRVRLQSASPSTRWTELDDVKRLLKGSRSASVSPTRNSSNTLPIPKKGTVETKIVTASSQSVSGTYDATILDANLPSHVWSSTLPAGSSMGTYHNNMTTQSSSLLNTNAYSAGSVFGVPNNMASCSPTLHPGLSTSSSVFGMQNNLAPSLTTLSHGTTTTSTAYGVKKNMPQSPAAVNTGVSTSAACTTSVQSDDLLHKDCKFLILEKDNTPAKKEMELLIMTKDSGKVFTASPASIAATSFSEDTLKKEKQAAYNADSGLKAEANGDLKTVSTKGKTTTADIHSYGSSGGGGSGGGGGVGGAGGGPWGPAPAWCPCGSCCSWWKWLLGLLLTWLLLLGLLFGLIALAEEVRKLKARVDELERIRRSILPYGDSMDRIEKDRLQGMAPAAGADLDKIGLHSDSQEELWMFVRKKLMMEQENGNLRGSPGPKGDMGSPGPKGDRGFPGTPGIPGPLGHPGPQGPKGQKGSVGDPGMEGPMGQRGREGPMGPRGEAGPPGSGEKGERGAAGEPGPHGPPGVPGSVGPKGSSGSPGPQGPPGPVGLQGLRGEVGLPGVKGDKGPMGPPGPKGDQGEKGPRGLTGEPGMRGLPGAVGEPGAKGAMGPAGPDGHQGPRGEQGLTGMPGIRGPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIKGEPGAPGKIVTSEGSSMLTVPGPPGPPGAMGPPGPPGAPGPAGPAGLPGHQEVLNLQGPPGPPGPRGPPGPSIPGPPGPRGPPGEGLPGPPGPPGSFLSNSETFLSGPPGPPGPPGPKGDQGPPGPRGHQGEQGLPGFSTSGSSSFGLNLQGPPGPPGPQGPKGDKGDPGVPGALGIPSGPSEGGSSSTMYVSGPPGPPGPPGPPGSISSSGQEIQQYISEYMQSDSIRSYLSGVQGPPGPPGPPGPVTTITGETFDYSELASHVVSYLRTSGYGVSLFSSSISSEDILAVLQRDDVRQYLRQYLMGPRGPPGPPGASGDGSLLSLDYAELSSRILSYMSSSGISIGLPGPPGPPGLPGTSYEELLSLLRGSEFRGIVGPPGPPGPPGIPGNVWSSISVEDLSSYLHTAGLSFIPGPPGPPGPPGPRGPPGVSGALATYAAENSDSFRSELISYLTSPDVRSFIVGPPGPPGPQGPPGDSRLLSTDASHSRGSSSSSHSSSVRRGSSYSSSMSTGGGGAGSLGAGGAFGEAAGDRGPYGTDIGPGGGYGAAAEGGMYAGNGGLLGADFAGDLDYNELAVRVSESMQRQGLLQGMAYTVQGPPGQPGPQGPPGISKVFSAYSNVTADLMDFFQTYGAIQGPPGQKGEMGTPGPKGDRGPAGPPGHPGPPGPRGHKGEKGDKGDQVYAGRRRRRSIAVKP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | KRDGTEVTERIVTET CCCCCCCHHHEEEEE | 17.20 | 29970186 | |
40 | Phosphorylation | KGGTSNGYAKTASLG CCCCCCCEEEEEECC | 14.80 | 19534553 | |
43 | Phosphorylation | TSNGYAKTASLGGGS CCCCEEEEEECCCCC | 17.20 | 23927012 | |
45 | Phosphorylation | NGYAKTASLGGGSRL CCEEEEEECCCCCCC | 32.55 | 23927012 | |
50 | Phosphorylation | TASLGGGSRLEKQSL EEECCCCCCCEEECC | 36.65 | 27251275 | |
56 | Phosphorylation | GSRLEKQSLTHGSSG CCCCEEECCCCCCCC | 46.43 | 23927012 | |
58 | Phosphorylation | RLEKQSLTHGSSGYI CCEEECCCCCCCCEE | 29.45 | 26657352 | |
61 | Phosphorylation | KQSLTHGSSGYINST EECCCCCCCCEECCC | 17.00 | 28731282 | |
62 | Phosphorylation | QSLTHGSSGYINSTG ECCCCCCCCEECCCC | 39.96 | 23927012 | |
64 | Phosphorylation | LTHGSSGYINSTGST CCCCCCCEECCCCCC | 10.01 | 23927012 | |
67 | Phosphorylation | GSSGYINSTGSTRGH CCCCEECCCCCCCCC | 25.29 | 23927012 | |
68 | Phosphorylation | SSGYINSTGSTRGHA CCCEECCCCCCCCCC | 30.57 | 25106551 | |
70 | Phosphorylation | GYINSTGSTRGHAST CEECCCCCCCCCCCC | 18.28 | 29743597 | |
71 | Phosphorylation | YINSTGSTRGHASTS EECCCCCCCCCCCCC | 41.85 | 23927012 | |
77 | Phosphorylation | STRGHASTSSYRRAH CCCCCCCCCCCCCCC | 23.60 | 26853621 | |
78 | Phosphorylation | TRGHASTSSYRRAHS CCCCCCCCCCCCCCC | 23.91 | 26853621 | |
79 | Phosphorylation | RGHASTSSYRRAHSP CCCCCCCCCCCCCCC | 23.81 | 29743597 | |
80 | Phosphorylation | GHASTSSYRRAHSPA CCCCCCCCCCCCCCC | 12.13 | - | |
85 | Phosphorylation | SSYRRAHSPASTLPN CCCCCCCCCCCCCCC | 22.60 | 28731282 | |
88 | Phosphorylation | RRAHSPASTLPNSPG CCCCCCCCCCCCCCC | 33.58 | 23927012 | |
89 | Phosphorylation | RAHSPASTLPNSPGS CCCCCCCCCCCCCCC | 48.63 | 23927012 | |
93 | Phosphorylation | PASTLPNSPGSTFER CCCCCCCCCCCCCCC | 28.79 | 28731282 | |
96 | Phosphorylation | TLPNSPGSTFERKTH CCCCCCCCCCCCEEC | 33.05 | 23927012 | |
97 | Phosphorylation | LPNSPGSTFERKTHV CCCCCCCCCCCEECE | 35.12 | 23927012 | |
105 | Phosphorylation | FERKTHVTRHAYEGS CCCEECEEECCCCCC | 14.77 | - | |
109 | Phosphorylation | THVTRHAYEGSSSGN ECEEECCCCCCCCCC | 18.07 | 23927012 | |
112 | Phosphorylation | TRHAYEGSSSGNSSP EECCCCCCCCCCCCC | 14.91 | 23927012 | |
113 | Phosphorylation | RHAYEGSSSGNSSPE ECCCCCCCCCCCCCC | 53.79 | 23927012 | |
114 | Phosphorylation | HAYEGSSSGNSSPEY CCCCCCCCCCCCCCC | 43.63 | 23927012 | |
117 | Phosphorylation | EGSSSGNSSPEYPRK CCCCCCCCCCCCCHH | 51.28 | 26657352 | |
118 | Phosphorylation | GSSSGNSSPEYPRKE CCCCCCCCCCCCHHH | 26.25 | 29743597 | |
121 | Phosphorylation | SGNSSPEYPRKEFAS CCCCCCCCCHHHHHC | 16.24 | 23927012 | |
128 | Phosphorylation | YPRKEFASSSTRGRS CCHHHHHCCCCCCCC | 30.09 | 27794612 | |
129 | Phosphorylation | PRKEFASSSTRGRSQ CHHHHHCCCCCCCCC | 32.09 | 27794612 | |
130 | Phosphorylation | RKEFASSSTRGRSQT HHHHHCCCCCCCCCC | 21.45 | 29743597 | |
131 | Phosphorylation | KEFASSSTRGRSQTR HHHHCCCCCCCCCCC | 38.81 | 27794612 | |
135 | Phosphorylation | SSSTRGRSQTRESEI CCCCCCCCCCCHHHH | 38.43 | 27794612 | |
137 | Phosphorylation | STRGRSQTRESEIRV CCCCCCCCCHHHHHH | 37.34 | 27794612 | |
140 | Phosphorylation | GRSQTRESEIRVRLQ CCCCCCHHHHHHHHH | 34.72 | 29743597 | |
148 | Phosphorylation | EIRVRLQSASPSTRW HHHHHHHCCCCCCCC | 34.99 | 28731282 | |
150 | Phosphorylation | RVRLQSASPSTRWTE HHHHHCCCCCCCCEE | 25.32 | 28731282 | |
152 | Phosphorylation | RLQSASPSTRWTELD HHHCCCCCCCCEEHH | 28.27 | 23927012 | |
153 | Phosphorylation | LQSASPSTRWTELDD HHCCCCCCCCEEHHH | 33.34 | 23927012 | |
156 | Phosphorylation | ASPSTRWTELDDVKR CCCCCCCEEHHHHHH | 24.31 | 20639409 | |
168 | Phosphorylation | VKRLLKGSRSASVSP HHHHHCCCCCCCCCC | 22.83 | 23090842 | |
170 | Phosphorylation | RLLKGSRSASVSPTR HHHCCCCCCCCCCCC | 26.96 | 29743597 | |
172 | Phosphorylation | LKGSRSASVSPTRNS HCCCCCCCCCCCCCC | 25.11 | 28731282 | |
174 | Phosphorylation | GSRSASVSPTRNSSN CCCCCCCCCCCCCCC | 20.33 | 28731282 | |
176 | Phosphorylation | RSASVSPTRNSSNTL CCCCCCCCCCCCCCC | 34.67 | 28985074 | |
179 | Phosphorylation | SVSPTRNSSNTLPIP CCCCCCCCCCCCCCC | 22.98 | 29743597 | |
180 | Phosphorylation | VSPTRNSSNTLPIPK CCCCCCCCCCCCCCC | 37.07 | 29743597 | |
182 | Phosphorylation | PTRNSSNTLPIPKKG CCCCCCCCCCCCCCC | 35.54 | 29743597 | |
303 | Phosphorylation | HGTTTTSTAYGVKKN CCCCCCCCCCCCCCC | 23.08 | 22817900 | |
305 | Phosphorylation | TTTTSTAYGVKKNMP CCCCCCCCCCCCCCC | 23.65 | 22817900 | |
320 | Phosphorylation | QSPAAVNTGVSTSAA CCCCCCCCCCCCCCC | 32.15 | 23532336 | |
352 | Phosphorylation | LILEKDNTPAKKEME EEEECCCCCCHHHEE | 34.45 | 23927012 | |
365 | Acetylation | MELLIMTKDSGKVFT EEEEEEECCCCCEEE | 32.30 | 19859113 | |
367 | Phosphorylation | LLIMTKDSGKVFTAS EEEEECCCCCEEECC | 41.91 | - | |
369 | Acetylation | IMTKDSGKVFTASPA EEECCCCCEEECCHH | 37.82 | 30586161 | |
372 | Phosphorylation | KDSGKVFTASPASIA CCCCCEEECCHHHHH | 29.25 | 29743597 | |
374 | Phosphorylation | SGKVFTASPASIAAT CCCEEECCHHHHHCC | 20.24 | 29743597 | |
377 | Phosphorylation | VFTASPASIAATSFS EEECCHHHHHCCCCC | 19.02 | 29743597 | |
381 | Phosphorylation | SPASIAATSFSEDTL CHHHHHCCCCCHHHH | 22.68 | 20639409 | |
382 | Phosphorylation | PASIAATSFSEDTLK HHHHHCCCCCHHHHH | 23.27 | 29743597 | |
384 | Phosphorylation | SIAATSFSEDTLKKE HHHCCCCCHHHHHHH | 34.04 | 23927012 | |
387 | Phosphorylation | ATSFSEDTLKKEKQA CCCCCHHHHHHHHHH | 36.10 | 29743597 | |
389 | Ubiquitination | SFSEDTLKKEKQAAY CCCHHHHHHHHHHHH | 62.06 | 22817900 | |
389 (in isoform 1) | Ubiquitination | - | 62.06 | 21906983 | |
389 (in isoform 2) | Ubiquitination | - | 62.06 | 21906983 | |
390 | Ubiquitination | FSEDTLKKEKQAAYN CCHHHHHHHHHHHHH | 73.57 | 22817900 | |
392 | Ubiquitination | EDTLKKEKQAAYNAD HHHHHHHHHHHHHCC | 54.86 | 22817900 | |
396 | Phosphorylation | KKEKQAAYNADSGLK HHHHHHHHHCCCCCE | 17.56 | 27259358 | |
400 | Phosphorylation | QAAYNADSGLKAEAN HHHHHCCCCCEEHHC | 43.55 | 17924679 | |
403 | Ubiquitination | YNADSGLKAEANGDL HHCCCCCEEHHCCCC | 47.94 | 22817900 | |
403 (in isoform 1) | Ubiquitination | - | 47.94 | 21906983 | |
403 (in isoform 2) | Ubiquitination | - | 47.94 | 21906983 | |
512 | Phosphorylation | IRRSILPYGDSMDRI HHHHHCCCCCCHHHH | 30.07 | - | |
515 | Phosphorylation | SILPYGDSMDRIEKD HHCCCCCCHHHHHHH | 20.44 | - | |
542 | Phosphorylation | LDKIGLHSDSQEELW HHHCCCCCCCHHHHH | 43.96 | 22817900 | |
544 | Phosphorylation | KIGLHSDSQEELWMF HCCCCCCCHHHHHHH | 42.37 | 8669466 | |
610 | Phosphorylation | GPKGQKGSVGDPGME CCCCCCCCCCCCCCC | 29.93 | 28674151 | |
640 | Phosphorylation | GEAGPPGSGEKGERG CCCCCCCCCCCCCCC | 49.94 | - | |
1124 | Phosphorylation | SGDGSLLSLDYAELS CCCCCEECCCHHHHH | 25.20 | - | |
1131 | Phosphorylation | SLDYAELSSRILSYM CCCHHHHHHHHHHHH | 14.74 | - | |
1284 | O-linked_Glycosylation | GDSRLLSTDASHSRG CCCCCCCCCCCCCCC | 35.24 | 55831783 | |
1284 | Phosphorylation | GDSRLLSTDASHSRG CCCCCCCCCCCCCCC | 35.24 | - | |
1287 | Phosphorylation | RLLSTDASHSRGSSS CCCCCCCCCCCCCCC | 25.46 | 28985074 | |
1289 | Phosphorylation | LSTDASHSRGSSSSS CCCCCCCCCCCCCCC | 35.52 | 28985074 | |
1295 | Phosphorylation | HSRGSSSSSHSSSVR CCCCCCCCCCCCCCC | 33.74 | 29759185 | |
1296 | Phosphorylation | SRGSSSSSHSSSVRR CCCCCCCCCCCCCCC | 29.36 | 29759185 | |
1298 | Phosphorylation | GSSSSSHSSSVRRGS CCCCCCCCCCCCCCC | 26.68 | 29759185 | |
1299 | Phosphorylation | SSSSSHSSSVRRGSS CCCCCCCCCCCCCCC | 27.68 | 29759185 | |
1300 | Phosphorylation | SSSSHSSSVRRGSSY CCCCCCCCCCCCCCC | 23.74 | 29759185 | |
1305 | Phosphorylation | SSSVRRGSSYSSSMS CCCCCCCCCCCCCCC | 25.04 | 23312004 | |
1306 | Phosphorylation | SSVRRGSSYSSSMST CCCCCCCCCCCCCCC | 31.68 | 23312004 | |
1307 | Phosphorylation | SVRRGSSYSSSMSTG CCCCCCCCCCCCCCC | 17.80 | 23312004 | |
1308 | Phosphorylation | VRRGSSYSSSMSTGG CCCCCCCCCCCCCCC | 20.20 | 23312004 | |
1309 | Phosphorylation | RRGSSYSSSMSTGGG CCCCCCCCCCCCCCC | 23.10 | 23312004 | |
1310 | Phosphorylation | RGSSYSSSMSTGGGG CCCCCCCCCCCCCCC | 15.71 | 23312004 | |
1312 | Phosphorylation | SSYSSSMSTGGGGAG CCCCCCCCCCCCCCC | 26.33 | 23312004 | |
1313 | Phosphorylation | SYSSSMSTGGGGAGS CCCCCCCCCCCCCCC | 31.07 | 23312004 | |
1395 | Phosphorylation | GLLQGMAYTVQGPPG CCCCCCEEECCCCCC | 9.88 | - | |
1421 | N-linked_Glycosylation | KVFSAYSNVTADLMD HHHHHHCCCCHHHHH | 23.60 | 9748270 | |
1421 | N-linked_Glycosylation | KVFSAYSNVTADLMD HHHHHHCCCCHHHHH | 23.60 | 9748270 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
542 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
544 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
544 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
544 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
544 | S | Phosphorylation |
| 17545155 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COHA1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DYST_HUMAN | DST | physical | 12482924 | |
ACTN4_HUMAN | ACTN4 | physical | 11739652 | |
ACTN1_HUMAN | ACTN1 | physical | 11739652 | |
ITB4_HUMAN | ITGB4 | physical | 9500991 | |
CTND1_HUMAN | CTNND1 | physical | 10321838 | |
K1C18_HUMAN | KRT18 | physical | 10022517 | |
DYST_HUMAN | DST | physical | 10637308 | |
PEPL_HUMAN | PPL | physical | 9521878 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00586 | Epidermolysis bullosa, junctional, including: Epidermolysis bullosa, junctional, Herlitz type (JEB-H | |||||
OMIM Disease | ||||||
226650 | Generalized atrophic benign epidermolysis bullosa (GABEB) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Two forms of collagen XVII in keratinocytes. A full-lengthtransmembrane protein and a soluble ectodomain."; Schaecke H., Schumann H., Hammami-Hauasli N., Raghunath M.,Bruckner-Tuderman L.; J. Biol. Chem. 273:25937-25943(1998). Cited for: SUBUNIT, PROTEOLYTIC PROCESSING, GLYCOSYLATION AT ASN-1421, ANDDOMAINS. | |
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-400, AND MASSSPECTROMETRY. | |
"Extracellular phosphorylation of collagen XVII by ecto-casein kinase2 inhibits ectodomain shedding."; Zimina E.P., Fritsch A., Schermer B., Bakulina A.Y., Bashkurov M.,Benzing T., Bruckner-Tuderman L.; J. Biol. Chem. 282:22737-22746(2007). Cited for: PHOSPHORYLATION AT SER-544. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-40; TYR-64 AND TYR-396,AND MASS SPECTROMETRY. |